GeneDx Holdings Corp. (WGSWW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for GeneDx Holdings Corp. (WGSWW:NASDAQ), powered by AI.

Current Price
$0.01
Sector
Healthcare
What is the GeneDx Holdings Corp. stock price forecast?

GeneDx Holdings Corp. is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.

What is GeneDx Holdings Corp. insider trading activity?

View the latest insider trading data for GeneDx Holdings Corp. on Alpha Lenz.

What is GeneDx Holdings Corp.'s P/E ratio?

View GeneDx Holdings Corp.'s valuation metrics on Alpha Lenz.

GeneDx Holdings Corp.

NASDAQ · WGSWW
$0.01-0.00(-21.79%)Market closedNASDAQ regular session 09:30–16:00 ET
Ask about GeneDx Holdings Corp.'s future dividend policy...
Alpha Chat Insight

GeneDx Holdings Corp.'s ROE is -22.1%. Explore profitability and growth together.

Ask for details

Company Overview

GeneDx Holdings Corp. is a recognized entity in the healthcare sector, primarily focusing on genomic testing and analysis. The company is dedicated to providing clinical genomic solutions that empower healthcare providers with precise and timely genetic information critical for diagnosing rare and complex genetic conditions. GeneDx serves a crucial role in the personalized medicine landscape, offering whole-exome sequencing and other advanced genetic tests. These services significantly impact various segments of the healthcare industry, including pediatrics, neurology, oncology, and cardiology, where precise genetic data can lead to more effective patient outcomes. By harnessing the power of genomics, GeneDx aids clinicians in making informed decisions and tailoring treatments according to individual genetic profiles, thus contributing to the broader efforts in disease prevention, management, and research. Its work in the genomic space highlights its importance in advancing medical knowledge and enhancing the capabilities of healthcare systems globally.

CEOMs. Katherine A. Stueland
SectorHealthcare
IndustryDiagnostics & Research
Employees1,000

Company Statistics

FY 2024

Profile

N/AMarket Cap
$305.45MRevenue
0.00Shares Out
1,000Employees

Margins

63.64%Gross
3.96%EBITDA
-7.60%Operating
-17.23%Pre-Tax
-17.12%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

12.91%Rev 3Yr
9.26%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-12.48%ROA
-22.10%ROE
-5.54%ROIC

Financial Health

$85.21MCash & Cash Equivalents
$88.92MNet Debt
71.00%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

GeneDx Holdings Corp. (ticker: WGSWW) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 1,000 employees.

The current price is $0.006 with a P/E ratio of -x and P/B of -x.

ROE is -22.10% and operating margin is -7.60%. Annual revenue is $305M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
GeneDx Holdings Corp. (Healthcare) Stock Forecast & Analysis $0.01 | Alpha Lenz